Results 81 to 90 of about 50,320 (220)
Artery Research, 2016 Purpose/ background/ objectives: People with or at risk of Type II diabetes (T2DM) are at increased risk of vascular disease and arterial stiffness (AS).
Charlotte Mills +8 more
doaj +1 more source
Therapeutic Effects and Safety of Spironolactone for Central Serous Chorioretinopathy [PDF]
, 2020 Jae Yong Han +2 more
openalex +1 more source
Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review [PDF]
, 2022 Shriya Rajashekar +9 more
openalex +1 more source
Evaluation of spironolactone plus hydrochlorothiazide in reducing proteinuria in type 2 diabetic nephropathy [PDF]
, 2015 Introduction: Inhibitors of the renin-angiotensin aldosterone system (RAAS) are the basic drugs for treatment of diabetic nephropathy, as to some extent is spironolactone.
Behradmanesh, Mohammad Saeed +3 more
core
, 2020 Objective: To compare different deep learning architectures for predicting the risk of readmission within 30 days of discharge from the intensive care unit (ICU).
Barbieri, Sebastiano +6 more
core +1 more source
Lack of effect of spironolactone on hair shaft diameter in hirsute females [PDF]
, 1989 A. R. McLellan +3 more
openalex +1 more source
Novel pathways of heart failure with preserved ejection fraction [PDF]
, 2016 INTRODUCTION: Diastolic heart failure (HF) i.e., HF with preserved ejection fraction (HFpEF) accounts for ~50% of all clinical HF presentations; but unlike systolic HF i.e., HF with reduced ejection fraction (HFrEF), there are no evidenced based ...
Li, Shanpeng
core +2 more sources
Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure [PDF]
, 2013 Spironolactone was likely to provide faster congestion relief. -------------------------------------------------------------------------------- Abstract Background/objectives Mineralocorticoid receptor antagonist (MRA) use in acutely ...
Almeida, S. +5 more
core +3 more sources
Drug interaction study in hospitalized hepatic cirrhosis patient in Dr.Ramelan navy hospital [PDF]
, 2009 Cirrhotic liver lead to some changes in pathophysiology such as reduction in liver blood flow, decrease some metabolic and synthetic function of the liver. Also there is a change in endothelial lining from hepatic sinusoid.
., Widyati +3 more
core